Terms: = Leukemia AND PSA AND Staging
5 results:
1. Incidental Finding of Acute Lymphocytic leukemia in a Prostate-Specific Membrane Antigen PET/CT.
Acksteiner C; Sounness B
Clin Nucl Med; 2019 Sep; 44(9):e529-e531. PubMed ID: 31306192
[TBL] [Abstract] [Full Text] [Related]
2. Synchronous mantle cell lymphoma and prostate adenocarcinoma-is it just a coincidence?
Petković I; Stojnev S; Krstić M; Pejčić I; Vrbić S
Vojnosanit Pregl; 2016 Nov; 73(11):1072-5. PubMed ID: 29341562
[TBL] [Abstract] [Full Text] [Related]
3. A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: a planned analysis of response, toxicity and quality of life in the GETUG 12 trial.
Fizazi K; Lesaunier F; Delva R; Gravis G; Rolland F; Priou F; Ferrero JM; Houedé N; Mourey L; Theodore C; Krakowski I; Berdah JF; Baciuchka M; Laguerre B; Fléchon A; Ravaud A; Cojean-Zelek I; Oudard S; Labourey JL; Lagrange JL; Chinet-Charrot P; Linassier C; Deplanque G; Beuzeboc P; Geneve J; Davin JL; Tournay E; Culine S
Eur J Cancer; 2012 Jan; 48(2):209-17. PubMed ID: 22119204
[TBL] [Abstract] [Full Text] [Related]
4. Prostatic extramedullary leukemia as a first site of relapse of acute nonlymphocytic leukemia.
Anderson GA; Braaten K
Urol Oncol; 2005; 23(6):419-21. PubMed ID: 16301120
[TBL] [Abstract] [Full Text] [Related]
5. Molecular staging of prostate cancer: comparison of nested reverse transcription polymerase chain reaction assay using prostate specific antigen versus prostate specific membrane antigen as primer.
Okegawa T; Yoshioka J; Morita R; Nutahara K; Tsukada Y; Higashihara E
Int J Urol; 1998 Jul; 5(4):349-56. PubMed ID: 9712443
[TBL] [Abstract] [Full Text] [Related]
